Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis
Mengyang Di,
Jessica B. Long,
Shalin K. Kothari,
Tarsheen Sethi,
Amer M. Zeidan,
Nikolai A. Podoltsev,
Rory M. Shallis,
Rong Wang,
Xiaomei Ma,
Scott F. Huntington
Affiliations
Mengyang Di
Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center
Jessica B. Long
Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center
Shalin K. Kothari
Section of Hematology, Department of Internal Medicine, Yale School of Medicine
Tarsheen Sethi
Section of Hematology, Department of Internal Medicine, Yale School of Medicine
Amer M. Zeidan
Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center
Nikolai A. Podoltsev
Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center
Rory M. Shallis
Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center
Rong Wang
Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT; Department of Chronic Disease Epidemiology, Yale School of Public Health
Xiaomei Ma
Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, New Haven, CT; Department of Chronic Disease Epidemiology, Yale School of Public Health
Scott F. Huntington
Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center
